Full-Time

MDM Engineering Manager

Amgen

Amgen

10,001+ employees

Develops biologic therapies for serious illnesses

No salary listed

Hyderabad, Telangana, India

In Person

Category
Engineering Management (1)
Required Skills
Python
SQL
AWS
Linux/Unix
Databricks
Requirements
  • Master’s degree with 8 - 10 years of experience in Business, Engineering, IT or related field OR
  • Bachelor’s degree with 10 - 14 years of experience in Business, Engineering, IT or related field OR
  • Diploma with 14 - 16 years of experience in Business, Engineering, IT or related field
  • Strong understanding and hands on experience of Databricks and AWS cloud services.
  • Proficiency in Python, PySpark, SQL, and Unix for data processing and orchestration.
  • Deep knowledge of MDM tools (Informatica, Reltio) and data quality frameworks (IDQ).
  • Strong experience with data modeling, governance, and DCR lifecycle management.
  • Proven leadership and project management in large-scale MDM implementations.
  • Able to implement end to end integrations including API based integrations, Batch integrations and Flat file based integrations
  • Strong experience with external data enrichments like D&B
  • Strong experience on match/merge and survivorship rules implementations
  • Must have worked on at least 3 end to end implementations of MDM
  • Very good understanding on reference data and its integration with MDM
  • Hands on experience with custom workflows
Responsibilities
  • Lead the implementation and optimization of MDM solutions using Informatica or Reltio platforms.
  • Define and drive enterprise-wide MDM architecture, including IDQ, data stewardship, and metadata workflows.
  • Design the solution and deliver enhanced MDM processes and data integrations using Unix, Python, and SQL.
  • Manage cloud-based infrastructure using AWS and Databricks to ensure scalability and performance.
  • Coordinate with business and IT stakeholders to align MDM capabilities with organizational goals.
  • Establish data quality metrics and monitor compliance using automated profiling and validation tools.
  • Promote data governance and contribute to enterprise data modeling and approval workflow (DCRs).
  • Ensure data integrity, lineage, and traceability across MDM pipelines and solutions.
  • Provide mentorship and technical leadership to junior team members and ensure project delivery timelines.
  • Lead custom UI design for better user experience on data stewardship.
Desired Qualifications
  • Experience with Tableau or PowerBI for reporting MDM insights.
  • Exposure to Agile practices and tools (JIRA, Confluence).
  • Prior experience in Pharma/Life Sciences.
  • Understanding of compliance and regulatory considerations in master data.

Amgen develops medicines aimed at treating serious illnesses, focusing on biotechnology. The company researches, develops, and sells biologic therapies, which are derived from living organisms, to address conditions like cancer, cardiovascular diseases, and autoimmune disorders. Amgen's products work by utilizing biological processes to create effective treatments for patients. Unlike many competitors, Amgen emphasizes a strong commitment to research and development, reinvesting a large portion of its earnings to discover new therapies. The company's goal is to improve patient care and outcomes by providing effective therapeutic solutions.

Company Size

10,001+

Company Stage

IPO

Headquarters

Thousand Oaks, California

Founded

1980

Simplify Jobs

Simplify's Take

What believers are saying

  • Acquisition of Micromet boosts Amgen's oncology portfolio with BiTE antibody blinatumomab.
  • Institutional investments indicate strong confidence in Amgen's financial health and prospects.
  • Amgen's AI-driven drug discovery investments could accelerate R&D capabilities.

What critics are saying

  • Micromet acquisition may face clinical or regulatory challenges impacting strategic goals.
  • Investor pressure for short-term gains may affect long-term R&D investments.
  • FTC scrutiny on mergers could hinder Amgen's future strategic growth.

What makes Amgen unique

  • Amgen focuses on biologic therapies derived from living organisms.
  • The company has a strong pipeline in oncology, cardiovascular, and autoimmune disorders.
  • Amgen's strategic acquisitions enhance its innovative medicine portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Conference Attendance Budget

Company News

Amgen
Jun 2nd, 2025
Amgen to Acquire Micromet| Amgen

The acquisition includes blinatumomab, a Bispecific T cell Engager (BiTE) antibody in Phase 2 clinical development for acute lymphoblastic leukemia (ALL). Blinatumomab is also in clinical development for the treatment of non-Hodgkin's lymphoma (NHL), and could have applications in other hematologic malignancies.

MarketBeat
Jan 28th, 2024
Factory Mutual Insurance Co. Makes New Investment in Amgen Inc. (NASDAQ:AMGN)

Factory Mutual Insurance Co. purchased a new position in Amgen Inc. (NASDAQ:AMGN - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 53,500 shares of the medical research company's stock, valued at approxim

The Quantum Insider
Jan 16th, 2024
Honeywell Announces the Closing of $300 Million Equity Investment Round for Quantinuum at $5 Billion Pre-Money Valuation

JPMorgan Chase has one of the world's most highly regarded specialist teams working on quantum technologies within the financial services industry and has been working with Quantinuum and its predecessor companies since 2020.

ETF Daily News
Dec 17th, 2023
Northwest Quadrant Wealth Management LLC Invests $237,000 in Amgen Inc. (NASDAQ:AMGN)

Northwest Quadrant Wealth Management LLC bought a new position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 883 shares of the medical research company’s stock, valued at approximately $237,000. A number of other institutional investors […]

Horizon Therapeutics
Sep 21st, 2023
Rule 2.7 Announcement: Amgen Inc to Acquire Horizon Therapeutics plc | Horizon Therapeutics plc

The Investor Relations website contains information about Horizon Therapeutics plc's business for stockholders, potential investors, and financial analysts.